Compared with simple steatosis, n-3 and n-6 LC-PUFAs in the liver of NASH patients are lower, which may be related to the overexpression of FADS1 and FADS2 genes [16]. The gene discussed is FADS1; the disease is metabolic dysfunction-associated steatohepatitis.